Bronchodilator responsiveness or reversibility in asthma and COPD - a need for clarity.
作者信息
Barjaktarevic Igor, Kaner Robert, Buhr Russell G, Cooper Christopher B
机构信息
Division of Pulmonary and Critical Care, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA,
Division of Pulmonary and Critical Care, Weill Cornell Medicine, NY, USA.
出版信息
Int J Chron Obstruct Pulmon Dis. 2018 Oct 23;13:3511-3513. doi: 10.2147/COPD.S183736. eCollection 2018.
Abstract
摘要
相似文献
1
Bronchodilator responsiveness or reversibility in asthma and COPD - a need for clarity.哮喘和慢性阻塞性肺疾病中的支气管扩张剂反应性或可逆性——需要明确界定。
Int J Chron Obstruct Pulmon Dis. 2018 Oct 23;13:3511-3513. doi: 10.2147/COPD.S183736. eCollection 2018.
2
Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome.哮喘-慢性阻塞性肺疾病重叠综合征的表型
Korean J Intern Med. 2015 Jul;30(4):443-9. doi: 10.3904/kjim.2015.30.4.443. Epub 2015 Jun 29.
3
The challenge of diagnosing a mixed asthma-COPD phenotype (ACOS) in clinical practice.临床实践中诊断哮喘-慢性阻塞性肺疾病混合表型（ACOS）的挑战。
Ther Adv Respir Dis. 2016 Apr;10(2):175-8. doi: 10.1177/1753465816630209.
4
The objective evaluation of obstructive pulmonary diseases with spirometry.通过肺量计对阻塞性肺疾病进行客观评估。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 25;11:2009-15. doi: 10.2147/COPD.S113774. eCollection 2016.
5
[New cholinergic drugs in asthma and COPD].[哮喘和慢性阻塞性肺疾病中的新型胆碱能药物]
Pneumonol Alergol Pol. 2002;70 Suppl 1:61-3.
6
Pepducins as a potential treatment strategy for asthma and COPD. Pepducins 作为哮喘和 COPD 的潜在治疗策略。
Curr Opin Pharmacol. 2018 Jun;40:120-125. doi: 10.1016/j.coph.2018.04.008. Epub 2018 May 2.
7
Sputum eosinophils and bronchodilator reversibility: COPD or asthma?痰液嗜酸性粒细胞与支气管扩张剂可逆性：慢性阻塞性肺疾病还是哮喘？
Chest. 2005 Jun;127(6):2292-3. doi: 10.1378/chest.127.6.2292-a.
8
Regional airflow obstruction after bronchoconstriction and subsequent bronchodilation in subjects without pulmonary disease.支气管收缩及随后支气管扩张后无肺部疾病患者的区域性气流阻塞。
J Appl Physiol (1985). 2019 Jul 1;127(1):31-39. doi: 10.1152/japplphysiol.00912.2018. Epub 2019 May 23.
9
[Tiotropium in asthma--a new opportunity?].噻托溴铵用于哮喘——新的契机？
Pneumologia. 2014 Oct-Dec;63(4):200-2.
10
Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.吸入性糖皮质激素与长效β2受体激动剂联合治疗哮喘-慢性阻塞性肺疾病重叠综合征。
Int J Chron Obstruct Pulmon Dis. 2016 Nov 8;11:2797-2803. doi: 10.2147/COPD.S114964. eCollection 2016.
引用本文的文献
1
A Systematic Review and Meta-Analysis Assessing the Impact of Improved Cookstove Technology Trials (ICTs) on Household Air Pollution and Human Health in Sub-Saharan Africa.一项系统评价与荟萃分析：评估改良炉灶技术试验（ICTs）对撒哈拉以南非洲家庭空气污染和人类健康的影响
Curr Environ Health Rep. 2025 Jan 28;12(1):8. doi: 10.1007/s40572-025-00476-9.
2
Patterns of bronchodilator therapy in asthmatic outpatients.哮喘门诊患者的支气管扩张剂治疗模式
J Public Health Afr. 2023 Mar 16;14(Suppl 1):2533. doi: 10.4081/jphia.2023.2533. eCollection 2023 Mar 30.
3
Fractional Dynamics Foster Deep Learning of COPD Stage Prediction.分数动力学促进 COPD 分期预测的深度学习。
Adv Sci (Weinh). 2023 Apr;10(12):e2203485. doi: 10.1002/advs.202203485. Epub 2023 Feb 19.
4
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.可逆性气流受限可预测SPIROMICS队列中未来慢性阻塞性肺疾病的发生：一项观察性队列研究。
Am J Respir Crit Care Med. 2022 Sep 1;206(5):554-562. doi: 10.1164/rccm.202201-0094OC.
5
Dissociating breathlessness symptoms from mood in asthma.将哮喘的呼吸困难症状与情绪区分开来。
Biol Psychol. 2021 Oct;165:108193. doi: 10.1016/j.biopsycho.2021.108193. Epub 2021 Sep 22.
6
Integrating Comorbidities and Phenotype-Based Medicine in Patient-Centered Medicine in COPD.在慢性阻塞性肺疾病的以患者为中心的医疗中整合合并症和基于表型的医学
J Clin Med. 2020 Aug 25;9(9):2745. doi: 10.3390/jcm9092745.
7
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.COPD 患者用力肺活量评估支气管扩张剂反应的临床意义：SPIROMICS 队列分析。
Int J Chron Obstruct Pulmon Dis. 2019 Dec 20;14:2927-2938. doi: 10.2147/COPD.S220164. eCollection 2019.
8
Effectiveness of Xin Jia Xuan Bai Cheng Qi Decoction in treating acute exacerbation of chronic obstructive pulmonary disease: study protocol for a multicentre, randomised, controlled trial.辛甲轩白承气汤治疗慢性阻塞性肺疾病急性加重期的有效性：一项多中心、随机、对照试验的研究方案。
BMJ Open. 2019 Nov 28;9(11):e030249. doi: 10.1136/bmjopen-2019-030249.
9
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.肺功能测定标准化 2019 修订版。美国胸科学会和欧洲呼吸学会官方技术声明。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
本文引用的文献
1
Making Sense of Triple Inhaled Therapy for COPD.理解慢性阻塞性肺疾病的三联吸入疗法
N Engl J Med. 2018 May 3;378(18):1723-1724. doi: 10.1056/NEJMe1716802. Epub 2018 Apr 18.
2
Use of clinical characteristics to predict spirometric classification of obstructive lung disease.利用临床特征预测阻塞性肺疾病的肺量计分类
Int J Chron Obstruct Pulmon Dis. 2018 Mar 12;13:889-902. doi: 10.2147/COPD.S153426. eCollection 2018.
3
Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction.轻度至中度气流阻塞患者慢性阻塞性肺疾病诊断的诊断不稳定性和逆转。
Am J Respir Crit Care Med. 2017 Aug 1;196(3):306-314. doi: 10.1164/rccm.201612-2531OC.
4
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.全球慢性阻塞性肺疾病诊断、管理和预防策略 2017 年报告：GOLD 执行摘要。
Eur Respir J. 2017 Mar 6;49(3). doi: 10.1183/13993003.00214-2017. Print 2017 Mar.
5
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.慢性阻塞性肺疾病全球策略：诊断、管理与预防 2017 年报告。GOLD 执行摘要。
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.
6
Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV in Severe Airflow Obstruction.在严重气流受限患者中，用力肺活量（FVC）的支气管扩张剂反应比第一秒用力呼气容积（FEV）更大且更具相关性。
Chest. 2017 May;151(5):1088-1098. doi: 10.1016/j.chest.2016.12.017. Epub 2016 Dec 28.
7
Progression to COPD in smokers with normal spirometry/low DLCO using different methods to determine normal levels.使用不同方法确定正常水平时，肺活量测定正常/弥散功能降低的吸烟者进展为慢性阻塞性肺疾病的情况。
Eur Respir J. 2016 Jun;47(6):1888-9. doi: 10.1183/13993003.00435-2016.
8
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.肺功能正常的吸烟者症状的临床意义
N Engl J Med. 2016 May 12;374(19):1811-21. doi: 10.1056/NEJMoa1505971.
9
Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps.COPD 气体陷闭和肺气肿的肺部成像生物标志物：（3）He MR 成像和 CT 参数响应图。
Radiology. 2016 May;279(2):597-608. doi: 10.1148/radiol.2015151484. Epub 2016 Jan 8.
10
The Asthma-COPD Overlap Syndrome.哮喘-慢阻肺重叠综合征。
N Engl J Med. 2015 Sep 24;373(13):1241-9. doi: 10.1056/NEJMra1411863.
Zotero 插件